1
/
of
1
Elabscience
SKU:PKSQ050112
Recombinant Cynomolgus Sialic acid-binding Ig-like lectin 15/Siglec-15/CD33L3 (C-Fc)
Recombinant Cynomolgus Sialic acid-binding Ig-like lectin 15/Siglec-15/CD33L3 (C-Fc)
Regular price
$200.00 USD
Regular price
Sale price
$200.00 USD
Unit price
/
per
Shipping calculated at checkout.
Couldn't load pickup availability
Introducing the Recombinant Cynomolgus Sialic acid-binding Ig-like lectin 15/Siglec-15/CD33L3 (C-Fc), a cutting-edge product designed to revolutionize the field of immunology. This meticulously engineered protein exhibits exceptional binding affinity towards sialic acid, enabling it to effectively interact with various cellular receptors and modulate immune responses.
Crafted through advanced recombinant technology, this Cynomolgus Sialic acid-binding Ig-like lectin 15/Siglec-15/CD33L3 (C-Fc) fusion protein showcases unparalleled purity and stability. Its fusion with the Fc region enhances its solubility and extends its half-life, ensuring optimal performance in a wide range of experimental settings.
The multifaceted functionality of this recombinant protein renders it an invaluable tool for researchers and scientists alike. Its ability to selectively bind to sialic acid moieties on target cells facilitates the investigation of intricate immunological processes, including cell adhesion, immune cell activation, and regulation of immune checkpoints.
Moreover, the Recombinant Cynomolgus Sialic acid-binding Ig-like lectin 15/Siglec-15/CD33L3 (C-Fc) offers exceptional versatility, making it suitable for a myriad of applications. Whether employed in cell-based assays, flow cytometry, or immunohistochemistry, this product consistently delivers reliable and reproducible results, empowering researchers to unravel the complexities of immune system dynamics.
In addition to its scientific merits, this recombinant protein is manufactured in strict adherence to rigorous quality control standards. Each batch undergoes meticulous testing to ensure its purity, integrity, and bioactivity, guaranteeing utmost confidence in experimental outcomes.
In summary, the Recombinant Cynomolgus Sialic acid-binding Ig-like lectin 15/Siglec-15/CD33L3 (C-Fc) represents a groundbreaking advancement in immunological research. With its exceptional binding affinity, enhanced stability, and versatile applications, this product is poised to revolutionize the understanding of immune responses and pave the way for novel therapeutic interventions.
Crafted through advanced recombinant technology, this Cynomolgus Sialic acid-binding Ig-like lectin 15/Siglec-15/CD33L3 (C-Fc) fusion protein showcases unparalleled purity and stability. Its fusion with the Fc region enhances its solubility and extends its half-life, ensuring optimal performance in a wide range of experimental settings.
The multifaceted functionality of this recombinant protein renders it an invaluable tool for researchers and scientists alike. Its ability to selectively bind to sialic acid moieties on target cells facilitates the investigation of intricate immunological processes, including cell adhesion, immune cell activation, and regulation of immune checkpoints.
Moreover, the Recombinant Cynomolgus Sialic acid-binding Ig-like lectin 15/Siglec-15/CD33L3 (C-Fc) offers exceptional versatility, making it suitable for a myriad of applications. Whether employed in cell-based assays, flow cytometry, or immunohistochemistry, this product consistently delivers reliable and reproducible results, empowering researchers to unravel the complexities of immune system dynamics.
In addition to its scientific merits, this recombinant protein is manufactured in strict adherence to rigorous quality control standards. Each batch undergoes meticulous testing to ensure its purity, integrity, and bioactivity, guaranteeing utmost confidence in experimental outcomes.
In summary, the Recombinant Cynomolgus Sialic acid-binding Ig-like lectin 15/Siglec-15/CD33L3 (C-Fc) represents a groundbreaking advancement in immunological research. With its exceptional binding affinity, enhanced stability, and versatile applications, this product is poised to revolutionize the understanding of immune responses and pave the way for novel therapeutic interventions.
Share
